Wei Jiang

TL;DR: A 69-year-old man with Covid-19 diagnosed in January 2020 in Wuhan, China, along with two other critically ill patients with Covod-19 who were also seen in the same intensive care unit are described.

TL;DR: The existence of hypercoagulation status in critical COVID-2019 patients with acro-ischemia should be monitored closely, and anticoagulation therapy can be considered in selected patients.

TL;DR: Multiple medium or high levels aPLs may help identify patients at risk of developing cerebral infarction and may trigger the development of “COVID‐19‐induced‐APS‐like‐syndrome”, which is one of the characteristics of critically ill patients with Coronavirus Disease 2019.

TL;DR: Sustained hypercoagulable status and thrombotic events were common in critically ill patients with COVID-19, and the low activities of natural anticoagulants, elevated factor VIII level and the presence of antiphospholipid antibodies, together, may contribute to the etiopathology of coagulopathy in CO VID-19 patients.

TL;DR: The standardized sepsis-related mortality rate in China was high and varied according to socioeconomic indices, even though some uncertainty remained.